U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: January 30 - February 5, 2022
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: January 30 - February 5, 2022

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Janet Woodcock, M.D., Acting Commissioner

Event Date: 02/02/2022
Location: Virtual
Subject: Trial Updates and Protocols
FDA Participant/Group: PETER STEIN;
Non FDA Participant/Group: Parties involved in Accelerating COVID-19 Therapeutic Interventions and Vaccines

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

Event Date: 02/04/2022
Location: Virtual
Subject: Alliance for Health Policy Webinar; Understanding FDA’s User Fee Programs
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, regulatory organizations, other stakeholders

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 02/01/2022
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several staff and members of the Consumer Brands Association

Event Date: 02/04/2022
Location: Virtual
Subject: Proposed Rule: Standards for the Growing, Harvesting, Packing, and Holding of Produce for Human Consumption Relating to Agricultural Water
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several American Indian and Alaska Native tribal leaders

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Jacqueline O'Shaughnessy, Acting Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 02/03/2022
Location: Virtual
Subject: House Energy and Commerce (E&C) Committee Hearing; FDA User Fee Reauthorization: Ensuring Safe and Effective Drugs and Biologics
FDA Participant/Group: PETER MARKS;
Non FDA Participant/Group: Juliana Reed (Biosimilars Forum);

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 02/01/2022
Location: Virtual
Subject: Massachusetts Medical Device Industry Council (MassMEDIC) Annual FDA Update: CDRH 2021 In Review
FDA Participant/Group: N/A
Non FDA Participant/Group: Members representing manufacturers, product developers, suppliers, research institutions, and academic health centers

Event Date: 02/02/2022
Location: Virtual
Subject: Strategic Innovation Projects and Regulatory Policy Collaboration Priorities
FDA Participant/Group: JAMES BERTRAM; BAKUL PATEL; KENNETH CAVANAUGH; WILLIAM MAISEL; CHRISTOPHER HARNER;
Non FDA Participant/Group: Ashley McEvoy, Peter Shen, Jennifer Paine, Robert Durgin (Johnson and Johnson)

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

Event Date: 01/31/2022
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: TRACEY FORFA; ANNE NORRIS; TIMOTHY SCHELL; JEANETTE MURPHY; SIOBHAN DELANCEY; DAVID EDWARDS; CHARLOTTE CONWAY; ANTONIA MONIQUE SENNETT;
Non FDA Participant/Group: Representatives from Pet Food Institute (PFI)

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

Back to Top